Active targeting of early and mid-stage atherosclerotic plaques using self-assembled peptide amphiphile micelles

Biomaterials

Volumn 35, Issue 30, 2014, Pages 8678-8686

  Mlinar, Laurie B ^a,b   Chung, Eun Ji ^b   Wonder, Emily A ^b   Tirrell, Matthew ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Atherosclerosis; Micelle; Peptide amphiphile; Self assembly; VCAM 1

Indexed keywords

BIOCOMPATIBILITY; BIOMOLECULES; DRUG DELIVERY; ENDOTHELIAL CELLS; FLUORESCENCE; SELF ASSEMBLY; SYNTHESIS (CHEMICAL); TISSUE;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; HISTOLOGICAL ANALYSIS; PEPTIDE AMPHIPHILES; SELF-ASSEMBLED PEPTIDES; TARGETED DRUG DELIVERY; VASCULAR CELL ADHESION MOLECULE-1; VCAM-1;

MICELLES;

AMPHOPHILE; CY7 LABELED PEPTIDE AMPHIPHILE MICELLE; FLUORESCENT DYE; MACROGOL 2000; PEPTIDE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; BIOMATERIAL; MACROGOL DERIVATIVE; MICELLE; PHOSPHATIDYLETHANOLAMINE; POLYETHYLENE GLYCOL-DISTEAROYLPHOSPHATIDYLETHANOLAMINE; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; BINDING AFFINITY; BIOACCUMULATION; BIOCOMPATIBILITY; CRITICAL MICELLE CONCENTRATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICELLE; MOUSE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; PLAQUE, ATHEROSCLEROTIC; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

MUS;

ANIMALS; BIOCOMPATIBLE MATERIALS; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE, TRANSGENIC; MICELLES; PEPTIDES; PHOSPHATIDYLETHANOLAMINES; PLAQUE, ATHEROSCLEROTIC; POLYETHYLENE GLYCOLS; SURFACE-ACTIVE AGENTS; TISSUE DISTRIBUTION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84904756157     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.06.054     Document Type: Article

References (39)

1. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., et al. Executive summary: heart disease and stroke statistics-2013 update a report from the American Heart Association. Circulation 2013, 127:143-152.
2. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
3. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006, 6:508-519.
4. Lewis D.R., Kamisoglu K., York A.W., Moghe P.V. Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011, 3:400-420.
5. Finn A.V., Nakano M., Narula J., Kolodgie F.D., Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010, 30:1282-1292.
6. Nahrendorf M., Jaffer F.A., Kelly K.A., Sosnovik D.E., Aikawa E., Libby P., et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006, 114:1504-1511.
7. Iiyama K., Hajra L., Iiyama M., Li H., DiChiara M., Medoff B.D., et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 1999, 85:199-207.
8. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001, 107:1255-1262.
9. Ley K., Huo Y. VCAM-1 is critical in atherosclerosis. J Clin Invest 2001, 107:1209-1210.
10. O'Brien K.D., Allen M.D., McDonald T.O., Chait A., Harlan J.M., Fishbein D., et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993, 92:945-951.
11. Nakashima Y., Raines E.W., Plump A.S., Breslow J.L., Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998, 18:842-851.
12. Dimastromatteo J., Broisat A., Perret P., Ahmadi M., Boturyn D., Dumy P., et al. In vivo molecular imaging of atherosclerotic lesions in ApoE(-/-) mice using VCAM-1-specific, 99mTc-labeled peptidic sequences. J Nucl Med 2013, 54:1442-1449.
13. Kelly K.A., Allport J.R., Tsourkas A., Shinde-Patil V.R., Josephson L., Weissleder R. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res 2005, 96:327-336.
14. Burtea C., Laurent S., Port M., Lancelot E., Ballet S., Rousseaux O., et al. Magnetic resonance molecular imaging of vascular cell adhesion molecule-1 expression in inflammatory lesions using a peptide-vectorized paramagnetic imaging probe. J Med Chem 2009, 52:4725-4742.
15. Michalska M., Machtoub L., Manthey H.D., Bauer E., Herold V., Krohne G., et al. Visualization of vascular inflammation in the atherosclerotic mouse by ultrasmall superparamagnetic iron oxide vascular cell adhesion molecule-1-specific nanoparticles. Arterioscler Thromb Vasc Biol 2012, 32:2350-2357.
16. Trent A., Marullo R., Lin B., Black M., Tirrell M. Structural properties of soluble peptide amphiphile micelles. Soft Matter 2011, 7:9572-9582.
17. Lukyanov A.N., Torchilin V.P. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev 2004, 56:1273-1289.
18. Peters D., Kastantin M., Kotamraju V.R., Karmali P.P., Gujraty K., Tirrell M., et al. Targeting atherosclerosis by using modular, multifunctional micelles. Proc Natl Acad Sci U S A 2009, 106:9815-9819.
19. Berndt P., Fields G.B., Tirrell M. Synthetic lipidation of peptides and amino acids: monolayer structure and properties. J Am Chem Soc 1995, 117:9515-9522.
20. Thapa N., Hong H.Y., Sangeetha P., Kim I.S., Yoo J., Rhee K., et al. Identification of a peptide ligand recognizing dysfunctional endothelial cells for targeting atherosclerosis. J Control Release 2008, 131:27-33.
21. Lien S., Lowman H.B. Therapeutic peptides. Trends Biotechnol 2003, 21:556-562.
22. Kelly K.A., Nahrendorf M., Yu A.M., Reynolds F., Weissleder R. In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging. Mol Imaging Biol 2006, 8:201-207.
23. Davies M.J., Gordon J.L., Gearing A.J., Pigott R., Woolf N., Katz D., et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993, 171:223-229.
24. Knorr R., Trzeciak A., Bannwarth W., Gillessen D. New coupling reagents in peptide chemistry. Tetrahedron Lett 1989, 30:1927-1930.
25. Fields G.B., Noble R.L. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res 1990, 35:161-214.
26. Chattopadhyay A., London E. Fluorimetric determination of critical micelle concentration avoiding interference from detergent charge. Anal Biochem 1984, 139:408-412.
27. Greenfield N., Fasman G.D. Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 1969, 8:4108-4116.
28. Whitman S.C. A practical approach to using mice in atherosclerosis research. Clin Biochem Rev 2004, 25:81-93.
29. Israelachvili J.N. Intermolecular and surface forces 2011, 538-550. Elsevier, San Diego. 3rd ed.
30. Marullo R., Kastantin M., Drews L.B., Tirrell M. Peptide contour length determines equilibrium secondary structure in protein-analogous micelles. Biopolymers 2013, 99:573-581.
31. Missirlis D., Farine M., Kastantin M., Ananthanarayanan B., Neumann T., Tirrell M. Linker chemistry determines secondary structure of p53(14-29) in peptide amphiphile micelles. Bioconjug Chem 2010, 21:465-475.
32. Tu R.S., Marullo R., Pynn R., Bitton R., Bianco-Peled H., Tirrell M.V. Cooperative DNA binding and assembly by a bZip peptide-amphiphile. Soft Matter 2010, 6:1035-1044.
33. Bruckman M.A., Jiang K., Simpson E.J., Randolph L.N., Luyt L.G., Yu X., et al. Dual-modal magnetic resonance and fluorescence imaging of atherosclerotic plaques in vivo using VCAM-1 targeted tobacco mosaic virus. Nano Lett 2014, 14:1551-1558.
34. Chung E.J., Cheng Y., Morshed R., Nord K., Han Y., Wegscheid M.L., et al. Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma. Biomaterials 2014, 35:1249-1256.
35. Diehl K.H., Hull R., Morton D., Pfister R., Rabemampianina Y., Smith D., et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 2001, 21:15-23.
36. Lukyanov A.N., Gao Z., Mazzola L., Torchilin V.P. Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice. Pharm Res 2002, 19:1424-1429.
37. Lobatto M.E., Fuster V., Fayad Z.A., Mulder W.J. Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat Rev Drug Discov 2011, 10:835-852.
38. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Ipe B.I., et al. Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1170.
39. Rao J. Shedding light on tumors using nanoparticles. ACS Nano 2008, 2:1984-1986.